2012
DOI: 10.1016/j.athoracsur.2011.11.031
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Angiographic Follow-Up of Robotic-Assisted Coronary Artery Revascularization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
39
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 57 publications
(41 citation statements)
references
References 20 publications
1
39
1
Order By: Relevance
“…One study provided separate data for both the TECAB offpump and robotic MIDCAB groups, and was included for analysis in both groups (10). Eighteen additional studies reported on a mixture of different surgical techniques (18,(34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53). A summary of the study selection process is presented in the PRISMA chart in Figure 1, and a summary of study characteristics is presented in Table 1.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…One study provided separate data for both the TECAB offpump and robotic MIDCAB groups, and was included for analysis in both groups (10). Eighteen additional studies reported on a mixture of different surgical techniques (18,(34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53). A summary of the study selection process is presented in the PRISMA chart in Figure 1, and a summary of study characteristics is presented in Table 1.…”
Section: Resultsmentioning
confidence: 99%
“…Twenty-one studies were excluded from the final analysis due to a mixed dataset for different surgical techniques (42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53) or use of cardiopulmonary bypass (36)(37)(38)(39)(40)(41), or use of an outdated robotic system other than the da Vinci system (18,34,35). Of the patients who were included for statistical analysis in the selected studies on off-pump TECAB, on-pump TECAB and robotic MIDCAB, the mean age ranged from 58 to 67, and 51-88% of patients were male.…”
Section: Resultsmentioning
confidence: 99%
“…Although the early clinical results of robotic CABG were excellent with acceptable graft patency [19], the longer term graft patency and the freedom from mortality and morbidity were still unclear. For TECAB, Bonatti and colleagues [20] analyzed the 5-year results and reported survival rates of 95.8% and 93.9% for single-and double-vessel disease, respectively [20], while Jegaden and colleagues [21] reported a 96% survival and 88% freedom form re-intervention at 3 years after surgery, and a study [22] showed a graft patency of 92.7% at 8 years after TECAB. Fewer studies on MINICAB were reported.…”
Section: Commentmentioning
confidence: 96%
“…The patency rate of all robotic-assisted CABG grafts was 92.7% with the patency rate of LITA to the LAD of 93.4%. 33 …”
Section: Current Resultsmentioning
confidence: 99%